查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519371

2024-2032 年按產品類型、平台、處方模式、最終用戶和地區分類的照護端診斷市場報告

Point-of-Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球IMARC Group診斷市場規模達到 492 億美元。對更快、更方便的診斷解決方案的需求不斷成長，全球傳染病流行率不斷上升，以及技術和小型化的進步是推動市場的一些關鍵因素。

即時診斷市場分析：

市場成長與規模：由於大眾各種慢性病的發生率不斷增加，全球即時診斷市場正在經歷適度成長。

主要市場促進因素：關鍵因素包括照護端工具的不斷發展以及對個人化醫療以改善患者治療效果的日益關注。

主要市場趨勢：主要趨勢包括投資研究活動，開發先進的測試解決方案和攜帶式照護端測試系統，以便在偏遠地區提供醫療保健服務。

地理趨勢：在醫療保健產業投資不斷增加的推動下，北美主導了市場。然而，由於大眾慢性病發生率不斷上升，亞太地區正成為成長最快的市場。

競爭格局：即時診斷行業的一些主要市場參與者包括 Abbott Laboratories、Beckman Coulter, Inc.、Becton、Dickinson and Company、F. Hoffmann-La Roche AG 等。這些公司正在投資研發 (R&D)，擴大其全球影響力，並專注於先進測試解決方案的開發。

挑戰與機會：挑戰包括需要高精度和經濟高效的解決方案。儘管如此，人們對個人化醫療益處的認知不斷提高，預計將克服這些挑戰。

即時診斷市場趨勢/促進因素：

慢性病盛行率不斷上升

根據世界衛生組織 (WHO) 統計，非傳染性疾病（也稱為慢性病）每年奪走 4,100 萬人的生命，相當於全球死亡人數的 74%。全球慢性病的增加正在推動對 POC 診斷服務的需求。糖尿病、心血管疾病和呼吸系統疾病等慢性病在大眾中越來越普遍，為全球醫療保健系統帶來了巨大挑戰。 POC 診斷為自發性檢測和持續監測這些健康併發症提供了寶貴的工具，有助於及時介入和有效的疾病管理。 POC 檢測的便利性和易用性進一步有助於慢性病的管理，特別是在傳統實驗室設施有限或無法使用的偏遠或農村地區。因此，慢性病的日益普及正在推動世界各地對即時診斷的需求。

各種技術進步

技術創新和整合在支持即時診斷市場成長方面發揮著至關重要的作用。小型化、生物感測器和連接方面的舉措和研究正在催生各種智慧和攜帶式診斷設備和系統。這些 POC 設備可以高精度地執行各種測試，而傳統的實驗室方法通常無法做到這一點。它們通常還與擴展的測試選單整合，以消除對多個設備的需求並減少獲取測試結果的周轉時間。

該公司還計劃生產尺寸緊湊並提供全面測試設施的 POC 診斷系統。主要市場參與者也與其他公司合作，提供獨特且可靠的診斷解決方案，以徹底改變醫療保健服務。 Molbio Diagnostics 於 2023 年宣布與 SigTuple 合作，開發下一代支援 AI 的攜帶式設備，用於許多常規和診斷測試。

對個人化醫療的日益重視

大眾對個人化醫療日益成長的需求正在推動市場的成長。美國國家癌症研究所 (NCI) 發起了一項大型精準醫學癌症計劃，以檢查使用各種新型藥物組合治療兒童和成人的有效性。

此外，隨著醫療保健行業正在轉向更加以患者為中心的方法，個人化醫療的接受度正在促進根據患者的需求制定治療計劃。 POC 診斷在此過程中發揮關鍵作用，因為它提供快速且有針對性的診斷解決方案，有助於精確的疾病識別和監測。它們為患者提供了關於治療和整體健康的保證感，這也是患者高度接受它們的原因。此外，根據 Coriell Life Sciences 的研究，證實精準醫療已達到全球採用的臨界點。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球照護端診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 血糖監測套件
    • 市場走向
    • 市場預測
  • 心臟代謝監測套件
    • 市場走向
    • 市場預測
  • 妊娠和生育力測試套件
    • 市場走向
    • 市場預測
  • 傳染病檢測試劑盒
    • 市場走向
    • 市場預測
  • 膽固醇試紙
    • 市場走向
    • 市場預測
  • 血液學檢測試劑盒
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按平台

  • 側流分析
    • 市場走向
    • 市場預測
  • 量油尺
    • 市場走向
    • 市場預測
  • 微流控
    • 市場走向
    • 市場預測
  • 分子診斷
    • 市場走向
    • 市場預測
  • 免疫測定
    • 市場走向
    • 市場預測

第 8 章：市場細分：依處方模式

  • 基於處方的測試
    • 市場走向
    • 市場預測
  • 場外測試
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 專業診斷中心
    • 市場走向
    • 市場預測
  • 居家護理
    • 市場走向
    • 市場預測
  • 研究實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格指標

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Instrumentation Laboratory
    • Johnson & Johnson
    • Nova Biomedical Corporation
    • Pts Diagnostics
    • Qiagen
    • Siemens
    • Trinity Biotech
Product Code: SR112024A2113

The global point-of-care diagnostics market size reached US$ 49.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The increasing demand for faster and more convenient diagnostic solutions, rising prevalence of infectious diseases across the globe, and advancements in technology and miniaturization represent some of the key factors driving the market.

Point-of-Care Diagnostics Market Analysis:

Market Growth and Size: The global point-of-care diagnostics market is experiencing moderate growth, on account of the increasing occurrence of various chronic diseases among the masses.

Major Market Drivers: Key factors include the growing development of point-of-care tools and the rising focus on personalized medicine for better patient outcomes.

Key Market Trends: Major trends include investments in research activities to develop advanced testing solutions and portable point-of-care testing systems for providing healthcare services in remote areas.

Geographical Trends: North America dominates the market, driven by rising investments in the healthcare sector. However, Asia Pacific is emerging as a fastest-growing market on account of the rising occurrence of chronic diseases among the masses.

Competitive Landscape: Some of the major market players in the point-of-care diagnostics industry include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, among many others. These companies are investing in research and development (R&D), expanding their global presence, and focusing on the development of advanced testing solutions.

Challenges and Opportunities: Challenges include the need for high accuracy and cost-effective solutions. Nonetheless, the rising awareness about the benefits of personalized medicines is projected to overcome these challenges.

Point-of-Care Diagnostics Market Trends/Drivers:

The growing prevalence of chronic diseases

According to the World Health Organization (WHO), non-communicable diseases, also called chronic diseases, kill 41 million people each year, which is equivalent to 74% of all deaths globally. The global rise in chronic diseases is driving the demand for POC diagnostic services. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent among the masses, posing substantial challenges to healthcare systems worldwide. POC diagnostics offer a valuable tool for spontaneous detection and continuous monitoring of these health complications, facilitating timely interventions and effective disease management. The convenience and easy availability of POC testing further contribute to the management of chronic diseases, especially in remote or rural areas where access to traditional laboratory facilities is limited or not available. Thus, the growing prevalence of chronic diseases is driving the point-of-care diagnostics demand around the world.

Various technological advancements

Technological innovations and integration play a crucial role in supporting the point-of-care diagnostics market growth. Initiatives and research in miniaturization, biosensors, and connectivity are leading to the creation of various smart and portable diagnostic devices and systems. These POC devices can perform a wide range of tests with high accuracy, which traditional laboratory-based methods often fail to deliver. They are also often integrated with expanded test menus to eliminate the need for multiple devices and reduce turnaround time for getting the test results.

Companies are also planning to produce POC diagnostics systems which are compact in size and offer comprehensive testing facilities. Key market players are also collaborating with other firms to offer unique and reliable diagnostic solutions to revolutionize healthcare delivery. Molbio Diagnostics declared its partnership with SigTuple in 2023 to develop next-generation AI-enabled portable devices for many routine and diagnostic tests.

The growing emphasis on personalized medicine

The increasing need for personalized medicine among the masses is propelling the growth of the market. The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to examine the effectiveness of treating children and adults with various novel drug combinations.

Moreover, as the healthcare sector is transitioning towards a more patient-centric approach, the acceptance of personalized medicine is facilitating the creation of treatment plans according to the needs of patients. POC diagnostics play a pivotal part in this procedure as it offers rapid and targeted diagnostic solutions that aid in precise disease identification and monitoring. They provide a sense of assurance to patients regarding their treatment and overall wellbeing, which is also responsible for their high acceptance among patients. Moreover, according to research done by Coriell Life Sciences, it is confirmed that precision medicine has reached a global tipping position for adoption.

Point-of-Care Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global point-of-care diagnostics market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, platform, prescription mode, and end-user.

Breakup by Product Type:

Blood-Glucose Monitoring Kit

Cardio-Metabolic Monitoring Kit

Pregnancy and Fertility Testing Kit

Infectious Disease Testing Kit

Cholesterol Test Strip

Hematology Testing Kit

Others

Blood-glucose monitoring kit represents the most popular product type

The report has provided a detailed breakup and analysis of the market based on product type. This includes blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit, and others. According to the report, blood-glucose monitoring kit represented the largest segment.

Blood-glucose monitoring kits are designed to be user-friendly, allowing patients to perform tests themselves without the need for specialized medical training. The simplicity and convenience of these kits are contributing to their widespread adoption, making them accessible to a broad spectrum of patients, including those in remote or underserved areas. Moreover, blood-glucose monitoring kits are often compact and portable, enabling patients to carry them wherever they go, thereby offering a favorable point-of-care diagnostics market outlook. Furthermore, on the basis of the predictions and research by the Institute for Health Metrics and Evaluation, global diabetes cases will increase from 529 million to 1.3 billion by 2050. The US Food and Drug Administration cleared the first over-the-counter (OTC) continuous glucose monitoring system (CGM) in the US -- the Dexcom Stelo Glucose Biosensor System. This will help people with Type 2 diabetes who don't need insulin to track their blood sugar for nonmedical purposes.

Breakup by Platform:

Lateral Flow Assays

Dipsticks

Microfluidics

Molecular Diagnostics

Immunoassays

Lateral flow assays represent the leading platform

A detailed breakup and analysis of the market based on the platform has also been provided in the report. This includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. According to the report, lateral flow assays hold the largest point-of-care diagnostics market share.

Lateral flow assays are known for their "simplicity" and "user-friendly" design. They are easy to use, requiring minimal training for both healthcare professionals and patients. The test procedure typically involves incorporating a samples like blood, saliva, and urine to a test strip, and the results are visually interpreted through the appearance of colored lines, eliminating the need for complex laboratory equipment. They offer stability over a wide range of environmental conditions and have a long shelf life. They also require small sample volume to conduct tests. As a result, various organizations and institutions are investing in the development of advanced lateral flow assays. For example, iiCON announced in 2021 that it will support Liverpool SME to develop advanced lateral flow tests, which can be performed with and without the addition of the Nano Biosols reagent.

Breakup by Prescription Mode:

Prescription-Based Testing

OTC Testing

Prescription-based testing currently dominates the market

The report has provided a detailed breakup and analysis of the market based on prescription mode. This includes prescription-based testing and OTC testing. According to the report, prescription-based testing represented the largest segment.

Prescription-based testing involves diagnostic tests that require a healthcare professional's order or prescription before they can be performed. These tests often undergo rigorous regulatory approval processes to ensure their safety, efficacy, and accuracy. The involvement of healthcare professionals in prescribing these tests ensures appropriate medical supervision and interpretation of the results, leading to better patient care and treatment decisions. Prescription-based testing is essential for the accurate detection, staging, and monitoring of diseases such as cancer, infectious diseases, cardiovascular disorders, and autoimmune conditions. As per the reports of WHO, over 35 million new cancer cases are predicted in 2050. This will further increase the need for prescription-based testing solutions.

Breakup by End-User:

Professional Diagnostic Centers

Home Care

Research Laboratories

Others

Professional diagnostic centers account for the majority of the market share

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes professional diagnostic centers, home care, research laboratories, and others. According to the report, professional diagnostic centers accounted for the largest market share.

Professional diagnostic centers offer a wide range of POC diagnostic tests, catering to various medical specialties and healthcare needs. These centers often have advanced equipment and well-trained personnel, allowing them to perform a diverse set of tests, including blood tests, rapid infectious disease testing, urinalysis, pregnancy tests, and more. The availability of comprehensive testing services makes professional diagnostic centers a preferred choice for both patients and healthcare providers. Moreover, professional diagnostic centers are staffed by qualified healthcare professionals, including medical technologists, clinical laboratory scientists, and physicians.

According to a report by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the Asia-Pacific Trade and Investment Trends 2022/2023 demonstrates that the pharmaceutical industry attracted the highest amount of FDI ($32 billion) between 2008 to 2021 - significantly more than investments in the medical devices ($20 billion), biotechnology ($17 billion) and healthcare ($10.8 billion) subsectors. This further increased the number of professional diagnostic centers providing comprehensive healthcare services.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for point-of-care diagnostics.

North America boasts a highly developed healthcare infrastructure with well-established medical facilities, laboratories, and diagnostic centers. The robust healthcare system of the region enables widespread adoption and integration of POC diagnostics into routine medical practice, contributing to their market dominance. Besides this, the high prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, is driving the demand for comprehensive testing services. POC diagnostics play a crucial role in the early detection, monitoring, and management of these chronic conditions.

As per a press release by the Centers for Disease Control and Prevention, the number of Americans with diabetes will range between 1 in 3 to 1 in 5 by 2050. This will further increase the demand for point-of-care testing solutions in the region.

Competitive Landscape:

The competitive landscape of the market is dynamic and characterized by the presence of numerous players, including established companies, emerging startups, and specialized firms and effective in answering queries related to how big is the point-of-care diagnostics market? Major players are heavily investing in R&D to innovate and develop cutting-edge POC diagnostic solutions. They are also focusing on improving the accuracy, sensitivity, and speed of their tests. Top companies are expanding the range of analytes and diseases that can be detected using POC devices. R&D efforts also involve exploring new technologies, such as biosensors, microfluidics, and lab-on-a-chip systems, to enhance the performance of POC diagnostics. They are also tailoring their products and marketing strategies to meet the specific healthcare needs and regulatory requirements of different countries. For example, Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions as an addition to its product offerings. The point-of-care diagnostics market statistics indicate a robust expansion trajectory, fueled by rising demands for rapid testing, technological innovation, and a growing emphasis on decentralized healthcare.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Beckman Coulter, Inc.

Becton Dickinson and Company

F. Hoffmann-La Roche AG

Instrumentation Laboratory

Johnson & Johnson

Nova Biomedical Corporation

Pts Diagnostics

Qiagen

Siemens

Trinity Biotech

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

January 2023: Beckman Coulter, Inc. announced that it has entered a strategic partnership with MeMed to develop and commercialize a host immune response diagnostic test.

January 2023: Becton Dickinson and Company presented educational grant funding towards 19 to Zero for a point-of-care testing pilot in the primary care setting.

Key Questions Answered in This Report

  • 1. What is the global point-of-care diagnostics market growth?
  • 2. What are the global point-of-care diagnostics market drivers?
  • 3. What are the key industry trends in the global point-of-care diagnostics market?
  • 4. What is the impact of COVID-19 on the global point-of-care diagnostics market?
  • 5. What is the global point-of-care diagnostics market breakup by product type?
  • 6. What are the major regions in the global point-of-care diagnostics market?
  • 7. Who are the key companies/players in the global point-of-care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point-of-Care Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hematology Testing Kit
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dipsticks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microfluidics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Molecular Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Immunoassays
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 OTC Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Beckman Coulter Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Instrumentation Laboratory
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nova Biomedical Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pts Diagnostics
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Qiagen
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Siemens
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Trinity Biotech
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Point-of-Care Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point-of-Care Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Point-of-Care Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Point-of-Care Diagnostics Market: Breakup by Platform (in %), 2023
  • Figure 5: Global: Point-of-Care Diagnostics Market: Breakup by Prescription Mode (in %), 2023
  • Figure 6: Global: Point-of-Care Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Point-of-Care Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Point-of-Care Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Point-of-Care Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Point-of-Care Diagnostics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Point-of-Care Diagnostics (Dipsticks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Point-of-Care Diagnostics (Dipsticks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Point-of-Care Diagnostics (Microfluidics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Point-of-Care Diagnostics (Microfluidics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Point-of-Care Diagnostics (Immunoassays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Point-of-Care Diagnostics (Immunoassays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Point-of-Care Diagnostics (OTC Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Point-of-Care Diagnostics (OTC Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Point-of-Care Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Point-of-Care Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Point-of-Care Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Point-of-Care Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Point-of-Care Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Point-of-Care Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia Pacific: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia Pacific: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Point-of-Care Diagnostics Industry: SWOT Analysis
  • Figure 94: Global: Point-of-Care Diagnostics Industry: Value Chain Analysis
  • Figure 95: Global: Point-of-Care Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point-of-Care Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Platform (in Million US$), 2024-2032
  • Table 4: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Prescription Mode (in Million US$), 2024-2032
  • Table 5: Global: Point-of-Care Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Point-of-Care Diagnostics Market: Competitive Structure
  • Table 8: Global: Point-of-Care Diagnostics Market: Key Players